Xenon Pharmaceuticals (XENE)
(Delayed Data from NSDQ)
$41.18 USD
+1.63 (4.12%)
Updated Jul 11, 2024 04:00 PM ET
After-Market: $41.19 +0.01 (0.02%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/14/2024
Time: -- |
6/2024 | $-0.72 | 0.00% |
Earnings Summary
For their last quarter, Xenon Pharmaceuticals (XENE) reported earnings of -$0.62 per share, beating the Zacks Consensus Estimate of $-0.69 per share. This reflects a positive earnings surprise of 10.14%. Look out for XENE's next earnings release expected on August 14, 2024. For the next earning release, we expect the company to report earnings of -$0.72 per share, reflecting no change in earnings compared to the year-ago quarter.
Earnings History
Price & Consensus
Zacks News for XENE
Xenon (XENE) Q1 Earnings Beat Estimates, Pipeline in Focus
XENE: What are Zacks experts saying now?
Zacks Private Portfolio Services